128 related articles for article (PubMed ID: 31489551)
1. MiR-194-5p in Pancreatic Ductal Adenocarcinoma Peritoneal Washings is Associated with Peritoneal Recurrence and Overall Survival in Peritoneal Cytology-Negative Patients.
Kubo H; Hiroshima Y; Mori R; Saigusa Y; Murakami T; Yabushita Y; Sawada Y; Homma Y; Kumamoto T; Matsuyama R; Endo I
Ann Surg Oncol; 2019 Dec; 26(13):4506-4514. PubMed ID: 31489551
[TBL] [Abstract][Full Text] [Related]
2. Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer.
Tokuhisa M; Ichikawa Y; Kosaka N; Ochiya T; Yashiro M; Hirakawa K; Kosaka T; Makino H; Akiyama H; Kunisaki C; Endo I
PLoS One; 2015; 10(7):e0130472. PubMed ID: 26208314
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma.
Jamieson NB; Morran DC; Morton JP; Ali A; Dickson EJ; Carter CR; Sansom OJ; Evans TR; McKay CJ; Oien KA
Clin Cancer Res; 2012 Jan; 18(2):534-45. PubMed ID: 22114136
[TBL] [Abstract][Full Text] [Related]
4. Pre-operative Plasma miR-21-5p Is a Sensitive Biomarker and Independent Prognostic Factor in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Resection.
Karasek P; Gablo N; Hlavsa J; Kiss I; Vychytilova-Faltejskova P; Hermanova M; Kala Z; Slaby O; Prochazka V
Cancer Genomics Proteomics; 2018; 15(4):321-327. PubMed ID: 29976637
[TBL] [Abstract][Full Text] [Related]
5. Expression of microRNA-218 in human pancreatic ductal adenocarcinoma and its correlation with tumor progression and patient survival.
Zhu Z; Xu Y; Du J; Tan J; Jiao H
J Surg Oncol; 2014 Feb; 109(2):89-94. PubMed ID: 24166773
[TBL] [Abstract][Full Text] [Related]
6. MiR-708-5p inhibits the progression of pancreatic ductal adenocarcinoma by targeting Sirt3.
Huang S; Guo H; Cao Y; Xiong J
Pathol Res Pract; 2019 Apr; 215(4):794-800. PubMed ID: 30683474
[TBL] [Abstract][Full Text] [Related]
7. Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma.
Nagao Y; Hisaoka M; Matsuyama A; Kanemitsu S; Hamada T; Fukuyama T; Nakano R; Uchiyama A; Kawamoto M; Yamaguchi K; Hashimoto H
Mod Pathol; 2012 Jan; 25(1):112-21. PubMed ID: 21983937
[TBL] [Abstract][Full Text] [Related]
8. Blood small extracellular vesicles derived miRNAs to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
Guo S; Qin H; Liu K; Wang H; Bai S; Liu S; Shao Z; Zhang Y; Song B; Xu X; Shen J; Zeng P; Shi X; Chen H; Gao S; Xu J; Pan Y; Xiong L; Li F; Zhang D; Jiao X; Jin G
Clin Transl Med; 2021 Sep; 11(9):e520. PubMed ID: 34586739
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of exosome-encapsulated microRNA-451a as a minimally invasive biomarker for prediction of recurrence and prognosis in pancreatic ductal adenocarcinoma.
Takahasi K; Iinuma H; Wada K; Minezaki S; Kawamura S; Kainuma M; Ikeda Y; Shibuya M; Miura F; Sano K
J Hepatobiliary Pancreat Sci; 2018 Feb; 25(2):155-161. PubMed ID: 29130611
[TBL] [Abstract][Full Text] [Related]
10. A novel feedback loop between high MALAT-1 and low miR-200c-3p promotes cell migration and invasion in pancreatic ductal adenocarcinoma and is predictive of poor prognosis.
Zhuo M; Yuan C; Han T; Cui J; Jiao F; Wang L
BMC Cancer; 2018 Oct; 18(1):1032. PubMed ID: 30352575
[TBL] [Abstract][Full Text] [Related]
11. Subclinical cancer cell dissemination in peritoneal lavage fluid detected by reverse-transcription polymerase chain reaction identifies patients at high risk for peritoneal recurrence and consequent impaired survival in the setting of preoperative chemoradiation therapy for pancreatic cancer.
Takahashi H; Akita H; Wada H; Tomokuni A; Asukai K; Takahashi Y; Yanagimoto Y; Matsunaga T; Sugimura K; Yamamoto K; Nishimura J; Yasui M; Omori T; Miyata H; Yamamoto T; Nakanishi M; Shirayanagi M; Yamasaki T; Ohue M; Yano M; Sakon M; Ishikawa O
Surgery; 2018 Dec; 164(6):1168-1177. PubMed ID: 30146098
[TBL] [Abstract][Full Text] [Related]
12. Circulating microRNAs in serum of human K-ras oncogene transgenic rats with pancreatic ductal adenocarcinomas.
Yabushita S; Fukamachi K; Tanaka H; Sumida K; Deguchi Y; Sukata T; Kawamura S; Uwagawa S; Suzui M; Tsuda H
Pancreas; 2012 Oct; 41(7):1013-8. PubMed ID: 22513294
[TBL] [Abstract][Full Text] [Related]
13. Molecular subtypes of pancreatic cancer based on miRNA expression profiles have independent prognostic value.
Namkung J; Kwon W; Choi Y; Yi SG; Han S; Kang MJ; Kim SW; Park T; Jang JY
J Gastroenterol Hepatol; 2016 Jun; 31(6):1160-7. PubMed ID: 26644397
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of intraoperative peritoneal washing cytology for patients with potentially resectable pancreatic ductal adenocarcinoma.
Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Hoshi N; Hoshi S; Hirabayashi K; Ogata Y
Pancreatology; 2017; 17(1):109-114. PubMed ID: 27840175
[TBL] [Abstract][Full Text] [Related]
15. High-throughput microRNA (miRNAs) arrays unravel the prognostic role of MiR-211 in pancreatic cancer.
Giovannetti E; van der Velde A; Funel N; Vasile E; Perrone V; Leon LG; De Lio N; Avan A; Caponi S; Pollina LE; Gallá V; Sudo H; Falcone A; Campani D; Boggi U; Peters GJ
PLoS One; 2012; 7(11):e49145. PubMed ID: 23155457
[TBL] [Abstract][Full Text] [Related]
16. MiR-371-5p facilitates pancreatic cancer cell proliferation and decreases patient survival.
He D; Miao H; Xu Y; Xiong L; Wang Y; Xiang H; Zhang H; Zhang Z
PLoS One; 2014; 9(11):e112930. PubMed ID: 25411783
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-593-3p Expression in Peritoneal Lavage Fluid as a Prognostic Marker for Pancreatic Cancer Patients Undergoing Staging Laparoscopy.
Hata T; Mizuma M; Masuda K; Chiba K; Ishida M; Ohtsuka H; Nakagawa K; Morikawa T; Kamei T; Unno M
Ann Surg Oncol; 2021 Apr; 28(4):2235-2245. PubMed ID: 33393045
[TBL] [Abstract][Full Text] [Related]
18. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.
Munding JB; Adai AT; Maghnouj A; Urbanik A; Zöllner H; Liffers ST; Chromik AM; Uhl W; Szafranska-Schwarzbach AE; Tannapfel A; Hahn SA
Int J Cancer; 2012 Jul; 131(2):E86-95. PubMed ID: 21953293
[TBL] [Abstract][Full Text] [Related]
19. RT-PCR of peritoneal washings predicts peritoneal pancreatic cancer recurrence.
Sato K; Mori R; Hiroshima Y; Oba MS; Matsuyama R; Bouvet M; Hoffman RM; Endo I
J Surg Res; 2018 Jun; 226():122-130. PubMed ID: 29661277
[TBL] [Abstract][Full Text] [Related]
20. Overexpressions of miR-212 are associated with poor prognosis of patients with pancreatic ductal adenocarcinoma.
Wu Z; Zhou L; Ding G; Cao L
Cancer Biomark; 2017; 18(1):35-39. PubMed ID: 27814273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]